ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.
Vander Lugt MT, Braun TM, Hanash S, Ritz J, Ho VT, Antin JH, Zhang Q, Wong CH, Wang H, Chin A, Gomez A, Harris AC, Levine JE, Choi SW, Couriel D, Reddy P, Ferrara JL, Paczesny S.
Vander Lugt MT, et al. Among authors: choi sw.
N Engl J Med. 2013 Aug 8;369(6):529-39. doi: 10.1056/NEJMoa1213299.
N Engl J Med. 2013.
PMID: 23924003
Free PMC article.